Question 1

What is Artelo Biosciences?

Accepted Answer

Artelo Biosciences is a Company.

Question 2

How often does Artelo Biosciences appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Artelo Biosciences first tracked by Ergen?

Accepted Answer

First tracked on Jul 13, 2026.

Question 4

When was Artelo Biosciences last mentioned in news?

Accepted Answer

Last active on Jul 13, 2026.

Question 5

What is Artelo Biosciences's current news sentiment?

Accepted Answer

Aggregate sentiment score: 10 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Artelo Biosciences in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Artelo Biosciences?

Accepted Answer

Artelo Biosciences ART27.13 Neuropathic Pain Results (Jul 13, 2026, 7 articles).

Question 8

How did the "Artelo Biosciences ART27.13 Neuropathic Pain Results" event impact Artelo Biosciences?

Accepted Answer

Artelo announced positive nonclinical results for ART27.13, supporting its pipeline in cancer supportive care. The stock declined slightly, reflecting mixed market reaction.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.